The term “anaplastic large cell lymphoma” (ALCL) was initially used to characterize a large-cell neoplasm having an anaplastic architecture that was marked by the CD30-specific Ki-1 antibody. The gene discussed is TNFRSF8; the disease is anaplastic large cell lymphoma.